Following on the heels of our partnership announcement with the FDA, we are thrilled to share that we have recently forged an agreement with Ethicon, a Johnson & Johnson company, to support and groom the next generation of medical device innovators. As part of the agreement, Ethicon will provide sponsorship for the Institute’s educational programming, as well as leadership and mentorship to its resident medtech innovators.
Ethicon offers healthcare professionals solutions that address the key challenges of today’s surgical procedures in order to optimize patient outcomes, and brings people together from around the world to create innovative solutions that advance surgery and improve lives every day.
“This exciting partnership with Ethicon is an important step towards advancing medical innovation,” said Ann Fyfe, President and CEO of the Fogarty Institute. “Support from world-class medtech leaders like Ethicon provides strong validation of our mission and approach, and we greatly appreciate the expertise they will share with our innovators. Today, more than ever before, early-stage medtech companies are challenged to bring their products to market while facing a tough regulatory and funding environment. Our innovators will greatly benefit from the mentorship and expertise brought by the highly experienced professionals at Ethicon and Johnson & Johnson. We are looking forward to a long-term partnership.”
The Fogarty Institute has supported the growth and vibrancy of the medtech industry since 2007, and this agreement is an extension of that commitment. We are looking forward to finalizing the 2016 programming curriculum for a long-term partnership that will help medical device entrepreneurs achieve critical development objectives that allow them to swiftly bring life-saving products to market and to patients.